Paulo J F Tucci Selected Research

Digitoxin

1/2020	Digitoxin Attenuates Heart Failure, Reduces Myocardial Hypertrophy, and Preserves the Calcium-Binding Proteins in Infarcted Rats.
7/2013	Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction.
10/2010	[Digoxin: the results of the DIG study in the XXI century].
11/2009	Digitoxin prolongs survival of female rats with heart failure due to large myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paulo J F Tucci Research Topics

Disease

16	Myocardial Infarction 01/2022 - 05/2002
11	Heart Failure 09/2022 - 08/2009
7	Coronary Occlusion 01/2020 - 04/2009
5	Hypertrophy 09/2022 - 06/2008
4	Fibrosis (Cirrhosis) 09/2022 - 10/2013
4	Infarction (Infarctions) 01/2020 - 04/2009
3	Necrosis 07/2010 - 06/2008
2	Cicatrix (Scar) 10/2013 - 05/2002
1	Ischemia 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Glucose Intolerance 01/2020
1	Stroke (Strokes) 01/2017
1	Microvascular Rarefaction 10/2013
1	Edema (Dropsy) 01/2012
1	Cardiomegaly (Heart Hypertrophy) 06/2008
1	Body Weight (Weight, Body) 06/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2010
5	salicylhydroxamic acid (SHAM)IBA 01/2020 - 04/2009
4	CollagenIBA 01/2020 - 06/2008
4	Digitoxin FDA Link 01/2020 - 11/2009
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2022 - 09/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 07/2010
2	VildagliptinIBA 09/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
1	Valsartan (Vals)FDA Link 09/2022
1	Angiotensin IIIBA 09/2022
1	phospholambanIBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	CalciumIBA 01/2020
1	CatalaseIBA 01/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	PeroxiredoxinsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2016
1	EnzymesIBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	SodiumIBA 01/2012
1	Evans Blue (Blue, Evans)FDA Link 01/2011
1	Digoxin (Digitek)FDA LinkGeneric 10/2010
1	CytokinesIBA 07/2010
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2010
1	Interleukin-6 (Interleukin 6)IBA 07/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2010
1	Interleukin-10 (Interleukin 10)IBA 07/2010
1	FibrinIBA 06/2009
1	Biopolymers (Biopolymer)IBA 06/2009
1	triphenyltetrazoliumIBA 05/2009
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2008

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2009
2	Low-Level Light Therapy (LLLT) 01/2022 - 01/2017
2	Hyperbaric Oxygenation 01/2020 - 05/2009
2	Radiofrequency Ablation 01/2016 - 08/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2013 - 06/2009
1	Resistance Training 01/2020
1	Lasers (Laser) 01/2017
1	Ligation 01/2016
1	Cell Transplantation 10/2013
1	Injections 06/2009
1	Aftercare (After-Treatment) 05/2009
1	Operative Surgical Procedures 05/2002